Abusive use of Zolpidem as a Result of COVID-19 and Perspectives of Continuity of the Problem in the Post-Pandemic Period.

de Lima, Wesley Dawison; da Silva, Michael Douglas; de Souza Costa, Eurico; Pinheiro, Francisco Irochima; de Azevedo, Eduardo Pereira; Cobucci, Ricardo Ney; Lopes de Paiva Cavalcanti, José Rodolfo; Guzen, Fausto Pierdoná.

Afiliação

de Lima WD; Graduation in Medicine, Health Science Center, State University of Rio Grande do Norte (UERN), Mossoró-RN, Brazil.
da Silva MD; Graduation in Medicine, Health Science Center, State University of Rio Grande do Norte (UERN), Mossoró-RN, Brazil.
de Souza Costa E; Posgraduate Program of Biotechnology, Health School - Potiguar University (UnP), Natal-RN, Brazil.
Pinheiro FI; Posgraduate Program of Biotechnology, Health School - Potiguar University (UnP), Natal-RN, Brazil.
de Azevedo EP; Posgraduate Program of Biotechnology, Health School - Potiguar University (UnP), Natal-RN, Brazil.
Cobucci RN; Posgraduate Program of Biotechnology, Health School - Potiguar University (UnP), Natal-RN, Brazil.
Lopes de Paiva Cavalcanti JR; Postgraduate Program in Physiological Sciences, Department of Biomedical Sciences, Faculty of Health Sciences, State University of Rio Grande do Norte (UERN), Mossoró-RN, Brazil.
Guzen FP; Posgraduate Program of Biotechnology, Health School - Potiguar University (UnP), Natal-RN, Brazil.

Curr Neuropharmacol ; 2023 Sep 20.

Article em En | MEDLINE | ID: mdl-37811654